To examine the contribution of endogenous FA synthesis to cellular proliferation, two types of prostate cancer cells, DU145 and LNCap, were treated with the ACC inhibitor 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA). The gene discussed is ACACA; the disease is Familial prostate cancer.